Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
RationaleCentral norepinephrine transporter (NET) is one of the main targets of antidepressants. Although the measurement of NET occupancy has been attempted in humans, the outcomes have been inconclusive.ObjectiveIn this study, the occupancy of NET by different doses of an antidepressant, nortriptyline, was measured using positron emission tomography (PET) with (S,S)-[18F]FMeNER-D2.Materials and methodsPET scans using (S,S)-[18F]FMeNER-D2 were performed on six healthy men before and after oral administration of a single oral dose of nortriptyline (10–75 mg). After a bolus i.v. injection of (S,S)-[18F]FMeNER-D2, dynamic scanning was performed for 0–90 min, followed by scanning for 120–180 min. The ratio of the thalamus-to-caudate areas under the curve (120–180 min) minus 1 was used as the binding potential (BPND) for NET. NET occupancy was calculated as the percentage reduction of BPND. Venous blood samples were taken to measure the concentrations of nortriptyline just before injection of the tracer and at 180 min after the injection.ResultsMean NET occupancies by nortriptyline were 16.4% at 10 mg, 33.2% at 25 mg, and 41.1% at 75 mg. The mean plasma concentration of nortriptyline was less than the lower limit of detection at 10 mg, 23.7 ng/mL at 25 mg, and 50.5 ng/mL at 75 mg. Estimated ED50 was 76.8 mg of administration dose and 59.8 ng/mL of plasma concentration.ConclusionsNET occupancy by nortriptyline corresponding to the administration dose of 10–75 mg or plasma concentration was observed from 16% to 41%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationHarmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554
Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · cited 4×
“…:M. Okumura :Y. Okubo Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan C. Halldin Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden pressants in living human brain (Meyer et al. 2001, 2004; Suhara et al. 2003).”
BackgroundInfluentialPapakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308 · cited 6×
“SSRIs are widely considered as the first choice of treatment for depression.”
BackgroundInfluentialMilnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
Vaishnavi, S. N., Nemeroff, C. B., Plott, S. J., Rao, S. G., Kranzler, J., & Owens, M. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.006 · Cited by 178 · cited 2×
“0 nmol/L) and dopamine transporter (Ki= 1,200 nmol/L) (Vaishnavi et al. 2004).”
BackgroundInfluentialA dose-finding study of duloxetine based on serotonin transporter occupancy
Takano, A., Suzuki, K., Kosaka, J., Ota, M., Nozaki, S., Ikoma, Y., Tanada, S., & Suhara, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0304-0 · Cited by 110 · cited 3×
“…of nortriptyline and NET occupancy is described by the following equation: Occupancy %ð Þ ¼ C C þ ED50 100; where C is the dose or plasma concentration of nortriptyline, and ED50 is the dose or plasma concentration required to induce 50% occupancy (Suhara et al. 2003; Takano et al. 2006).”
BackgroundSelf-citation
Cited by
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
Arakawa, R., Stenkrona, P., Takano, A., Svensson, J., Andersson, M., Nag, S., Asami, Y., Hirano, Y., Halldin, C., & Lundberg, J. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz003 · Cited by 70
“The applicability of [18F] FMeNER-D2 PET in clinical occupancy studies have been shown in several reports (Sekine et al., 2010; Nogami et al., 2013; Nyberg et al., 2013; Takano et al., 2014; Moriguchi et al., 2017a).”
BackgroundSelf-citationMoriguchi, S., Takano, H., Kimura, Y., Nagashima, T., Takahata, K., Kubota, M., Kitamura, S., Ishii, T., Ichise, M., Zhang, M.-R., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx069 · Cited by 47
Self-citationArakawa, R., Tateno, A., Kim, W., Sakayori, T., Ogawa, K., & Okubo, Y. (2016) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2016.03.006 · Cited by 16
Self-citation
Metadata
- Authors
- Sekine, M., Arakawa, R., Ito, H., Okumura, M., Sasaki, T., Takahashi, H., Takano, H., Okubo, Y., Halldin, C., & Suhara, T.
- Venue
- Psychopharmacology
- Published
- 2010-03-23
- Volume
- 210
- Issue
- 3
- Pages
- 331-336
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2059359840
- Cited by
- 39
- References
- 6
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2. https://app.cochat.ai/papers/10.1007/s00213-010-1824-9
- The paper
- Sekine, M., Arakawa, R., Ito, H., Okumura, M., Sasaki, T., Takahashi, H., Takano, H., Okubo, Y., Halldin, C., & Suhara, T. (2010). Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2. Psychopharmacology. https://doi.org/10.1007/s00213-010-1824-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.